http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102861296-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_410957a0059dc940e9c24ddb495ba8b5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 |
| filingDate | 2012-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_217ad216c00465a2c879b51f0b35077b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd3670470e1988d704aa4d412749aa80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_309f275c843ac7f0fa3ff80d251d4cb1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b221cdfd3f09d93229aa532a428d0db2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31e5a91555c70476d0884b36246544b0 |
| publicationDate | 2014-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102861296-B |
| titleOfInvention | Pill inducing diuresis and reducing edema for treating gonarthromeningitis |
| abstract | The invention discloses a pill inducing diuresis and reducing edema for treating gonarthromeningitis. In parts by weight, the pill inducing diuresis and reducing edema consists of fried astragalus, atractylodes rhizome, poria cocos, semen coicis, powder yam rhizome, plantain seed, rhizome alismatis, leonurus, radix rehmanniae recen, golden cypress, honeysuckle stem, dogwood, rhizome sparganii and curcuma zedoary. The pill is prepared by grinding and evenly mixing the raw materials, adding microcrystalline cellulose and water and mixing evenly. By treating gonarthromeningitis with the pill, the treatment curative effect is remarkable, the treatment course is short, the cost is low, and toxic and side effect is avoided. The effective rate of the curative effect is as high as 95%. |
| priorityDate | 2012-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.